Shengnuo Biotech announced that Chengdu Shengnuo Biopharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for linaclotide capsules issued by the State Drug Administration. The drug's specification is 290 μg, and the registration classification is 4 types of chemicals. It has been approved for registration and issued a drug registration certificate.

Zhitongcaijing · 1d ago
Shengnuo Biotech announced that Chengdu Shengnuo Biopharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for linaclotide capsules issued by the State Drug Administration. The drug's specification is 290 μg, and the registration classification is 4 types of chemicals. It has been approved for registration and issued a drug registration certificate.